GHP February 2018

Q1 2018

Click below to read this months issue!

Welcome to the first issue of GHP Magazine for 2018, your source for the latest news and exciting features.

In this month’s issue, we look at how the Alliance for Safe Biologic Medicines (ASBM) has recently announced that it has developed a web-based tool for the naming of biologic medicines to quickly ensure compliance with naming standards set forth by the FDA and World Health Organization (WHO). The tool, called “SuffixAudit”, will be made available to regulators and manufacturers.

Also in recent news, the latest Healthtech M&A Report from international technology mergers and acquisitions advisors, Hampleton Partners, has revealed how the ‘perfect storm’ of rapidly converging digital technologies and societal changes, coupled with the entrance of tech giants, such as Amazon into the healthcare and medical systems market, is driving intense innovation and M&A activity in the Healthtech sector.

Elsewhere in this edition, one of the largest plastics, chemicals and refining companies in the world, LyondellBasell is bringing to market the new Purell RP375R – a polypropylene (PP) random copolymer that delivers excellent resistance to gamma and X-ray radiation sterilisation.

Finally, over the past two decades, Harley Street Clinic Founder & Skin Expert, Zaheda Hafez has been inspired by her clients that she has advised at her award-winning firm. Utilising her expertise to create Zaheda Skincare, in collaboration with leading cosmetic scientists, we profile both the product and examine what makes it so successful.

Here at GHP Magazine, we hope that you thoroughly enjoy reading this edition and look forward to hearing from you.

GHP November 2017 (Texas A M University)

GHP November 2017 (Texas A M University)

Welcome to the November edition of GHP Magazine, providing you with a diverse range of news and exciting features.

In recent news, a late-stage life sciences investment firm that partners with companies to successfully bring novel medical therapies to market, Aisling Capital announced on the 2nd November the closing of its newest fund, with $280 million in committed capital. The capital raised will allow Aisling Capital to continue helping clinical stage ventures improve global health by more rapidly bringing breakthrough medical treatments to market.

Gracing the cover of this month’s issue, Texas A&M is one of the largest universities in the United States of America, with a current student body of more than 60,000 and a physical campus of more than 5,200 acres. We profiled the University in order to explore the secrets behind its success and what will help it go further in the future.

Speaking of success, founded in 2009, Cytosurge has invested considerable time and money to turn a laboratory idea into a commercially viable technology. We profiled the firm in order to find out what clients can expect when working with the company.

Lastly, we discover more about independent, internationally recognized health care accrediting body, Accreditation Commission for Health Care (ACHC). The organisation is focused on helping providers demonstrate compliance with applicable standards of practice and care. We learn more about accrediting body when we spoke to ACHC President and CEO, José Domingos to find out more about ACHC’s compliance solutions.

Here at GHP Magazine, we hope that you truly enjoy reading this edition and look forward to hearing from you soon.

GHP November 2017 (Rejuvenation Dentistry)

GHP November 2017 (Rejuvenation Dentistry)

Welcome to the last edition of GHP Magazine for 2017, showcasing a diverse range of news and exciting features.

In recent news, a late-stage life sciences investment firm that partners with companies to successfully bring novel medical therapies to market, Aisling Capital announced on the 2nd November the closing of its newest fund, with $280 million in committed capital. The capital raised will allow Aisling Capital to continue helping clinical stage ventures improve global health by more rapidly bringing breakthrough medical treatments to market.

Gracing the cover of this month’s issue, we find out more about Rejuvenation Dentistry when we profiled the firm to discover more about founder, Dr. Gerry Curatola, his holistic approach to dentistry and, what makes the business the success we know it is today.

Speaking of success, founded in 2009, Cytosurge has invested considerable time and money to turn a laboratory idea into a commercially viable technology. We profiled the firm in order to find out what clients can expect when working with the company.

Lastly, we discover more about independent, internationally recognized health care accrediting body, Accreditation Commission for Health Care (ACHC). The organisation is focused on helping providers demonstrate compliance with applicable standards of practice and care. We learn more about accrediting body when we spoke to ACHC President and CEO, José Domingos to find out more about ACHC’s compliance solutions.

Here at GHP Magazine, we hope that you enjoy reading this informative edition and look forward to hearing from you.

GHP August 2017

GHP August 2017

 Welcome to the August edition of GHP Magazine

In this edition, we learn more about how researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage.

Elsewhere, we take a glimpse at privately held company with Canadian and U.S. shareholders, Dealers Ingredients. Finding out more about the quality natural ingredients they have been supplying to leading food manufactures across Canada since 1976.

Finally, we discover how performance across Scotland’s accident and emergency departments was above the 95% target during June this year.

I hope you enjoy reading this informative issue.

Strathclyde University: A World without Anti-Infective Drugs?

Strathclyde University: A World without Anti-Infective Drugs?

It’s hard to imagine that anyone with access to any mainstream news medium could be unaware of the problem of microbial resistance to drugs and the threat to vast populations of people and animals that would arise from an inability to control infectious diseases. We speak to Professor Colin J Suckling OBE, DSc, FRSE, Research Professor of Chemistry at the Department of Pure & Applied Chemistry at the University of Strathclyde.

GHP July 2017

GHP July 2017

Welcome to the July edition of GHP magazine.

In this edition, we invited Chief Executive Officer of PCMC, Mr Chong Yee Mun to discuss with us the work at PMC, and how it strives to be the leading healthcare provider in Asia.

Medibio Limited is pleased to announce the appointment of Dr Adam Darkins, MB, ChB., MPHM, M.D., FRCS to the board of directors as deputy chairman, to the digital health company which has developed an objective testing system to assist in the screening, diagnosis and treatment effectiveness of depression, chronic stress and other mental health disorders.

Elsewhere in this issue, Chairperson & CSO of United Biomedical Inc. (UBI), Chang Yi Wang, Ph.D takes time to inform us about the privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialisation of immunotherapeutics and vaccines for chronic and infectious diseases.

I hope you truly enjoy reading this edition.

GHP June 2017

GHP June 2017

Welcome to the June edition of GHP

Welcome to the June edition of GHP Magazine, featuring a whole host of innovative content from the future of virtual scanning to animal welfare, as well as sports nutrition packaging.

Technology is transforming the life sciences and healthcare supply chain, in just three ways: Real-time tracking, risk management and demanded prediction capabilities.

Elsewhere, we spoke with the President and CEO of Polaryx Therapeutics, Inc., Hahn-Jun Lee to discover about their recent research into a small molecule based non-invasive therapy, for late infantile Neuronal ceroid lipofuscinosis.

I truly hope that you thoroughly enjoy this edition.

Jessie Daykin – Editor

GHP May 2017

GHP May 2017

Welcome to the May edition of Global Health & Pharma.

In recent news, INSIGHTEC congratulated Nicklaus Children’s Hospital, part of the Miami Children’s Health System, for performing the first focused ultrasound procedure on a 21-year old patient suffering seizures associated with a benign hypothalamic hamartoma brain tumour.

We also find out that one in eight consumers in England (13%) have had their personal medical information stolen from technology systems, according to results of a new survey from Accenture.

In contract news, Crawford Healthcare, the UK’s fastest growing advanced wound care company, has won a key government tender that will see its innovative wound dressings recommended as products of choice by Abu Dhabi’s public health body.

I hope you enjoy reading the array of content that this edition offers.

GHP April 2017

GHP April 2017

Welcome to the April edition of Global Health & Pharma.

In recent news, Teva Pharmaceuticals Europe BV announced the launch of ‘Get it Right’ – an engaging, disease awareness campaign aiming to challenge the public’s and physician’s mind-set in managing asthma, through education on how to use asthma inhalers correctly.

In contract news, Crawford Healthcare, the UK’s fastest growing advanced wound care company, has won a key government tender that will see its innovative wound dressings recommended as products of choice by Abu Dhabi’s public health body.

We also learn more about Altogen Labs, an Austin, TX based contract research organization (CRO) founded in 2009, offering preclinical laboratory services to pharmaceutical, biotechnology and academic researchers worldwide to support and accelerate medical discovery and research studies.

I hope you enjoy reading all that this edition has to offer.

The World Depends upon Heterocyclic Chemistry

The World Depends upon Heterocyclic Chemistry

This is the first of a series of three e-books for Global Health & Pharma that I’m writing based upon the projects I’ve to which I’ve contributed at the University of Strathclyde in Glasgow as a researcher and manager over the past 40 years or so.

GHP February 2017

GHP February 2017

Welcome to the February edition of Global Health & Pharma.

In recent research, we find out that the emerging cardiac therapies market in the United States and Western Europe is advancing at double-digit rates, propelled by the growing adoption of minimally invasive procedures by interventional cardiologists, technology advancements, supportive reimbursement policies and a rising aged population.

On the subject of research, an in-depth feature by Immunservice reveals the development of innovative well-tolerated therapeutic use of cytokines, in particular interleukin-2, the major immune-modulating hormone in humans and animals.

Turning to animal health, IFAH-Europe recently welcomed the European Medicines Agency’s and the European Food Safety Agency’s summary conclusions of their joint opinion on EU measures to reduce the need to use antimicrobials in animal husbandry as an important acknowledgement that there is no perfect farming system.

I hope you enjoy reading this edition.

GHP December 2016

GHP December 2016

Welcome to the December issue of GHP Magazine.
As 2016 rolls into its closing stretches, this issue looks back with pride on the past year on the milestones that have been reached, the innovations achieved, the lives saved, through the vigilant work of thousands upon thousands of companies and institutions, comprising countless individuals, as they battle to overcome the challenges of their respective markets to ensure affordable and reliable healthcare for all.

To begin with, GHP pays particular notice to the technological breakthroughs and developments of recent months; the application of new child-proof safety containers and bio-friendly plastic films, made from all-new low-gauge materials, spell out a secure and safe future not only for Locked4Kids and PolyPak America, but for the millions of consumers that utilise these products every day. The potential to avert mishaps and even deaths is an opportunity that should be embraced readily, well into the future.

It is not only the applications and development of human medicine that GHP pays close attention to – the world of veterinary care is also a crucial area of focus, and this issue pays attention to the selfless services of such institutions dedicated to animal care as the Sierra Lione Animal Welfare Society, whose mission to curtail rabies in the West of Africa has drawn international attention and encouraged a greater awareness for the contagious disease.

Indeed, funding and investment continues to remain a central component of the ongoing development of the healthcare and pharmaceutical industries. While the Northamptonshire charity Animals in Need relies upon the donations of food, toys and bedding as well as finances from the public to support over 600 animals, there is an observable effort across all markets to capitalise upon an age of advanced medicine to develop new approaches to maintaining a consistent level of care for all those that require it. This is also why technological innovations such as Quanticate’s RCDM solutions represent such a fresh, holistic perspective towards tackling any future challenges faced by in the global healthcare industry.

We at GHP Magazine wish you all a Happy Christmas and New Year, and we will return in January.